pharma-company /Medicinal products /Active ingredients

Rx · PZN 18190165

VAXIGRIP Tetra 2023-2024 suspension for injection pre-filled syringe with needle

German trade nameVAXIGRIP Tetra 2023-2024 Injektionssuspension Fertigspritze mit Kanüle

Active ingredientInfluenza, inactivated, split virus or surface antigenSubstance (DE)Influenza, inaktiviert, Spaltvirus oder OberflächenantigenPharmaceutical formPre-filled syringe

According to the data available to us: no longer marketed

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

N/A

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.


VAXIGRIP Tetra 2023-2024 suspension for injection pre-filled syringe with needle contains the active ingredient Influenza, inactivated, split virus or surface antigen (German Influenza, inaktiviert, Spaltvirus oder Oberflächenantigen) and comes as Pre-filled syringe. One pack size is recorded (PZN 18190165). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability. According to our records, none of the recorded packs is currently marketed on a regular basis – sources of supply can be checked on request.


According to the data available to us, VAXIGRIP Tetra 2023-2024 suspension for injection pre-filled syringe with needle is no longer regularly marketed. We help you identify successor products, remaining stock and import routes.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. No purchase price is available to us for this product.